Belite Bio (BLTE) Total Current Liabilities (2021 - 2025)
Belite Bio (BLTE) posted Total Current Liabilities of $14.95 million for Q2 2026, up 129.2% from $6.52 million a year earlier but down 3.5% from the prior quarter.
Powered by 
Analysis
Belite Bio (BLTE) Total Current Liabilities (2021 - 2025) Analysis & Trends
At the end of FY2025, Belite Bio's Total Current Liabilities came in at $10.07 million, up 66.4% from FY2024.
- Annual Total Current Liabilities has increased for four consecutive years, with a four-year compound annual growth rate of 57.5% (FY2021 to FY2025).
- In prior years, Belite Bio's Total Current Liabilities was $6.05 million in FY2024 (+66.5%), $3.63 million in FY2023 (+72.7%), $2.1 million in FY2022 (+28.7%) and $1.64 million in FY2021.
- Quarterly Total Current Liabilities has run from a low of $1.43 million in Q2 2022 to a high of $15.48 million in Q1 2026 over five years.
- On a year-over-year basis, Total Current Liabilities has increased in each of the last seven quarters, with growth averaging 76.7% over the last eight quarters.
- The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2023, with growth of 249.1%; the weakest was Q3 2024, with a decline of 24.6%.
- According to Business Quant data, Total Current Liabilities for the three prior quarters was $15.48 million (Q1 2026), $10.07 million (Q4 2025) and $8.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Belite Bio | 5.16 Bn | 5.16 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.88 Mn |
| Sep 30, 2025 | 8.07 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Dec 31, 2023 | 3.63 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 1.64 Mn |
API Access
Belite Bio Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BLTE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "BLTE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BLTE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();